| |
| |
|
| Insider
Information: |
Kaufmann Michael C |
| Relationship: |
Director |
| City: |
Dublin |
| State: |
OH |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
613,483 |
|
|
Indirect Shares
|
10 |
|
|
| Direct
Value |
$58,841,671 |
|
|
|
Indirect Value
|
$961 |
|
|
| Total
Shares |
613,493 |
|
|
| Total
Value |
$58,842,632 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cardinal Health Inc |
CAH |
CEO, Director |
2022-08-15 |
601,065 |
2022-08-15 |
10 |
Premium* |
|
|
MSC Industrial Direct Co Inc |
MSM |
Director |
2024-01-26 |
12,418 |
2015-09-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
113 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2012-08-16 |
4 |
D |
$39.81 |
$13,894 |
D/D |
(349) |
108,216 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2010-09-15 |
4 |
D |
$31.79 |
$14,115 |
D/D |
(444) |
77,616 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2012-09-15 |
4 |
D |
$38.37 |
$14,657 |
D/D |
(382) |
107,834 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-08-16 |
4 |
D |
$41.60 |
$16,848 |
D/D |
(405) |
79,096 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-09-15 |
4 |
D |
$41.58 |
$18,462 |
D/D |
(444) |
78,652 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2010-12-03 |
4 |
S |
$37.29 |
$23,605 |
I/I |
(633) |
0 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2013-08-16 |
4 |
D |
$51.49 |
$28,422 |
D/D |
(552) |
115,969 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CFO |
• – – |
2017-12-01 |
4 |
D |
$59.19 |
$32,614 |
D/D |
(551) |
230,435 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-10-26 |
4 |
OE |
$27.29 |
$54,580 |
D/D |
2,000 |
80,652 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2010-08-15 |
4 |
D |
$31.36 |
$57,452 |
D/D |
(1,832) |
56,408 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-08-15 |
4 |
D |
$40.87 |
$59,343 |
D/D |
(1,452) |
79,501 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2012-08-15 |
4 |
D |
$39.77 |
$79,620 |
D/D |
(2,002) |
108,565 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
Chief Executive Officer |
• • – |
2018-12-03 |
4 |
D |
$54.83 |
$89,702 |
D/D |
(1,636) |
271,264 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-10-26 |
4 |
AS |
$44.95 |
$89,900 |
D/D |
(2,000) |
78,652 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO |
• • – |
2021-12-01 |
4 |
D |
$46.23 |
$129,352 |
D/D |
(2,798) |
549,654 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO |
• • – |
2019-12-02 |
4 |
D |
$55.03 |
$136,860 |
D/D |
(2,487) |
410,411 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
Chief Executive Officer |
• • – |
2018-08-15 |
4 |
D |
$50.17 |
$162,400 |
D/D |
(3,237) |
280,254 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO |
• • – |
2020-12-01 |
4 |
D |
$54.59 |
$175,016 |
D/D |
(3,206) |
444,529 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2010-02-01 |
4 |
D |
$33.07 |
$202,157 |
D/D |
(6,113) |
58,507 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-04-27 |
4 |
OE |
$32.33 |
$327,923 |
D/D |
10,143 |
72,303 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-05-05 |
4 |
OE |
$32.33 |
$327,923 |
D/D |
10,143 |
72,303 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-07-01 |
4 |
OE |
$32.33 |
$327,923 |
D/D |
10,143 |
72,303 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO |
• • – |
2020-06-28 |
4 |
D |
$50.55 |
$336,107 |
D/D |
(6,649) |
403,762 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO |
• • – |
2020-11-08 |
4 |
D |
$52.64 |
$341,370 |
D/D |
(6,485) |
447,735 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO |
• • – |
2019-11-08 |
4 |
D |
$53.20 |
$353,142 |
D/D |
(6,638) |
412,898 |
0 |
- |
|
113 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
